1. Home
  2. SNFCA vs CGEN Comparison

SNFCA vs CGEN Comparison

Compare SNFCA & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$9.66

Market Cap

233.9M

Sector

Finance

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.82

Market Cap

188.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNFCA
CGEN
Founded
1965
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
188.2M
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
SNFCA
CGEN
Price
$9.66
$2.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
28.5K
485.8K
Earning Date
05-14-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
13.51
N/A
EPS
1.26
N/A
Revenue
$344,587,538.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$7.67
N/A
Revenue Growth
3.01
N/A
52 Week Low
$7.70
$1.23
52 Week High
$11.00
$3.24

Technical Indicators

Market Signals
Indicator
SNFCA
CGEN
Relative Strength Index (RSI) 54.10 59.14
Support Level $9.50 $1.45
Resistance Level $9.78 N/A
Average True Range (ATR) 0.19 0.18
MACD -0.02 0.00
Stochastic Oscillator 40.91 53.93

Price Performance

Historical Comparison
SNFCA
CGEN

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: